Road2HardCoreIron

The user's query contains a misspelling: "parteyits" likely refers to lipodystrophy or lipohypertrophy, which are lumps of fatty tissue that can form at injection sites.
Yes, Novorapid (insulin aspart) injections can potentially cause lipodystrophy, especially if you inject into the same area repeatedly. Lipodystrophy refers to changes in the fatty tissue under the skin, which can include both lipohypertrophy (thickening of the skin) and lipoatrophy (thinning of the skin).
How Novorapid can cause lipodystrophy
Insulin's effect on fat cells: When you inject insulin into the same spot frequently, the insulin can cause the fat cells in that specific area to increase in size and accumulate, leading to a visible lump.
Needle reuse: Reusing the same needle can also increase the risk of developing these lumps.
Improper absorption: Injecting into an area with lipodystrophy can cause a problem with how your body absorbs the insulin. The absorption can become unpredictable, leading to fluctuating blood sugar levels.
How to prevent lipodystrophy
The primary way to prevent lipodystrophy is to rotate your injection sites consistently.
Vary injection areas: Use different areas of your body for injections, such as your abdomen, thighs, buttocks, and upper arms.
Map your injections: Keep a record of where you inject to ensure you are not using the same spot too often.
Change needles: Use a fresh, new needle for every injection.
Inspect and palpate: Regularly check and feel your injection sites for any signs of lumps or changes in texture.
If you notice skin changes at your injection sites, talk to your doctor or diabetes educator. They can help you with proper injection techniques and site rotation. If you have developed lipodystrophy, you should avoid injecting insulin into the affected area until it has healed.